泛素羧基末端水解酶L1在自发性蛛网膜下腔出血中的探索性价值:预测临床结局与迟发性脑缺血
本研究为前瞻性观察性研究,纳入102例自发性蛛网膜下腔出血成人患者,于发病后24小时、72小时和7天检测血清UCH-L1水平。结果显示入院24小时UCH-L1是不良结局和迟发性脑缺血的独立预测因子,预测14天和3个月不良结局的最佳截断值为174.6 pg/mL。
要点
- 入院24小时血清UCH-L1可独立预测sSAH患者不良功能结局和迟发性脑缺血。
- UCH-L1预测14天和3个月不良结局的最佳截断值为174.6 pg/mL。
- UCH-L1有望作为指导sSAH早期预防和治疗干预的生物标志物。
核心结论
- 早期血清UCH-L1水平是sSAH患者临床结局、死亡率和迟发性脑缺血的显著预测因子。
研究设计与样本
- 前瞻性观察性研究,2022年1月至2024年6月纳入102例神经影像确诊的成人(≥18岁)sSAH患者。
- 于sSAH发病后24小时(T0)、72小时(T1)和7天(T2)采集血样,使用自动分析仪检测UCH-L1水平。
主要发现
- 入院24小时UCH-L1水平是不良结局的独立预测因子(P < .001)。
- 入院24小时UCH-L1水平是迟发性脑缺血的独立预测因子(P = .026)。
- 预测14天不良结局的UCH-L1最佳截断值为174.6 pg/mL(OR 10.55,95% CI 4.23-26.36)。
- 预测3个月不良结局的UCH-L1最佳截断值为174.6 pg/mL(OR 7.79,95% CI 3.11-19.52)。
关键数值与推荐
- 预测14天不良结局的UCH-L1截断值174.6 pg/mL,OR 10.55(95% CI 4.23-26.36)。
- 预测3个月不良结局的UCH-L1截断值174.6 pg/mL,OR 7.79(95% CI 3.11-19.52)。
临床怎么用
- 入院24小时检测血清UCH-L1有助于早期识别sSAH后不良结局和迟发性脑缺血高危患者。
- UCH-L1可作为指导sSAH早期预防性和治疗性干预的潜在生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Spontaneous subarachnoid hemorrhage (sSAH) is a critical neurological condition with high mortality and significant long-term sequelae. Delayed cerebral ischemia (DCI) is a significant contributor to poor clinical outcomes. Despite advances in management, early predictors of clinical outcomes and DCI remain unclear. This study investigates whether serum ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), a neuronal injury biomarker, can predict functional outcomes, mortality, and DCI in patients with sSAH. METHODS: A prospective observational study was conducted from January 2022 to June 2024, enrolling adults (≥18 years) with sSAH confirmed by neuroimaging on admission. Blood samples were collected at 24 hours (T0), 72 hours (T1), and 7 days (T2) after sSAH onset. UCH-L1 levels were measured using an automated analyzer. Outcomes were functional status, assessed by the modified Rankin Scale at 14 days and 3 months, mortality, the occurrence of DCI, and determination of UCH-L1 cutoff values predictive of poor prognosis. RESULTS: A total of 102 patients with sSAH were included. UCH-L1 levels measured 24 hours after admission were independent predictors of poor outcomes ( P < .001) and DCI ( P = .026). The optimal UCH-L1 cutoff for predicting poor outcomes at 14 days and 3 months was 174.6 pg/mL (odds ratio 10.55, 95% CI 4.23-26.36 and odds ratio 7.79, 95% CI 3.11-19.52, respectively). CONCLUSION: Early serum UCH-L1 levels are significant predictors of clinical outcomes, mortality, and DCI in patients with sSAH, suggesting that UCH-L1 could be a promising biomarker for guiding early prophylactic and therapeutic interventions in the management of sSAH.
引用
- Auricchio AM, Baroni S, Nichelatti M, et al. Explorative Values of Ubiquitin Carboxy-Terminal Hydrolase L1 in Spontaneous Subarachnoid Hemorrhage: Prediction of Clinical Outcomes and Delayed Cerebral Ischemia. Neurosurgery. 2025. PMID: 40824026. doi:10.1227/neu.0000000000003689
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。